Scott D. Grimes - 02 Jul 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDLX	Common Stock	Sale	$114,014	-928	-1.2%	$122.86^*	76,184	02 Jul 2021	See Footnote	F1, F2, F3
transaction	CDLX	Common Stock	Sale	$70,682	-572	-0.75%	$123.57^*	75,612	02 Jul 2021	See Footnote	F1, F3, F4
transaction	CDLX	Common Stock	Sale	$37,476	-300	-0.4%	$124.92^*	75,312	02 Jul 2021	See Footnote	F1, F3, F5
transaction	CDLX	Common Stock	Sale	$25,966	-200	-0.27%	$129.83^*	75,112	02 Jul 2021	See Footnote	F1, F3, F6
holding	CDLX	Common Stock						240,674	02 Jul 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019, as amended March 12, 2020.
F2	The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $122.34 to $123.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6) to this Form 4.
F3	The reportable securities are held by the GRAT.
F4	The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $123.36 to $123.72, inclusive.
F5	The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.64 to $125.14, inclusive.
F6	The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $129.61 to $130.05, inclusive.